Career & Filing History
Every role Anthony Mancini has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
Anthony Mancini is a corporate insider at Revolution Medicines, Inc. (RVMD). Mancini has reported 4 insider filings with the SEC since 2026. The most recent filing was in June 2026.
Every role Anthony Mancini has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
Revolution Medicines, Inc. (RVMD)1 filingUpdated Aug 30, 2026
Anthony Mancini is Chief Global Commercialization Officer of Revolution Medicines, Inc. (RVMD). 4 SEC Form 4 filings on record, most recently on 18 June 2026. Most recent open-market trade: sold $720K of RVMD on 18 June 2026. Lifetime open-market sales: $5.19M.
Every recent SEC Form 4 transaction Anthony Mancini has reported, most recent first.
InsiderAlpha's records for Anthony Mancini go back to 2026: 4 primary Form 4 filings, an average of 4.0 per year. 17 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Insiders who reported open-market trades in the last 12 months at the companies Anthony Mancini files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Anthony Mancini is a corporate insider, tracked as Chief Global Commercialization Officer of Revolution Medicines, Inc. (RVMD). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
1 primary Form 4 filing in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases and 12 open-market sales ($5.19M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial